Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)
HKD 11.4
(-1.89%)
HKD 11.4
(-1.89%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 89.13 Million CNY | -6.28% |
| 2022 | 95.1 Million CNY | 528.15% |
| 2021 | 15.14 Million CNY | 89.72% |
| 2020 | 7.98 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 6.89 Million CNY | -92.26% |
| 2024 Q2 | 6.89 Million CNY | 0.0% |
| 2023 Q4 | 89.13 Million CNY | 800.69% |
| 2023 FY | 89.13 Million CNY | -6.28% |
| 2023 Q3 | 9.89 Million CNY | -31.04% |
| 2023 Q2 | 14.35 Million CNY | -21.24% |
| 2023 Q1 | 18.22 Million CNY | -80.84% |
| 2022 Q1 | 29.07 Million CNY | 92.01% |
| 2022 FY | 95.1 Million CNY | 528.15% |
| 2022 Q4 | 95.1 Million CNY | 300.75% |
| 2022 Q3 | 23.73 Million CNY | -12.69% |
| 2022 Q2 | 27.17 Million CNY | -6.5% |
| 2021 Q3 | 21.65 Million CNY | 0.0% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 FY | 15.14 Million CNY | 89.72% |
| 2021 Q4 | 15.14 Million CNY | -30.08% |
| 2020 FY | 7.98 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 36.39 Million HKD | -144.922% |
| CK Life Sciences Int'l., (Holdings) Inc. | 1.2 Billion HKD | 92.6% |